Intracranial Stenosis Stents Market Size & Share, By Product (Self-expanding Stents, Embolization Coil Support Intracranial Stents, Venous Sinus Stents, Balloon-expanding), End-use, Regional Forecast, Industry Players, Growth Statistics Report 2023-2030

Market Outlook:

Intracranial Stenosis Stents Market size surpassed USD 0.75 Billion in 2022 and is poised to reach USD 1.21 Billion, growing at over 5.52% CAGR between 2023 and 2030. This market valuation can be attributed to several key factors, including an increasing prevalence of intracranial stenosis, advancements in stent technology, rising surgical interventions for the treatment of cerebrovascular diseases, and the growing geriatric population.

• Base Year Value (2022): USD 0.75 Billion
• CAGR (2023-2030): 5.5%
• Forecast Year Value (2030): USD 1.21 Billion
• Historical Data Period: 2018-2021
• Largest Region: North America
• Forecast Period: 2023-2030

Market Dynamics:

Growth Drivers & Opportunities:

1. Increasing Prevalence of Intracranial Stenosis: The rising incidence of intracranial stenosis, which is predominantly observed in the aging population, is a significant driver for the market. Factors such as high blood pressure, diabetes, obesity, and smoking contribute to the development of intracranial stenosis, thereby boosting the demand for stent implants.

2. Advancements in Stent Technology: Technological advancements in intracranial stenosis stents have greatly improved their efficacy and safety. The introduction of self-expanding stents and drug-eluting stents has led to enhanced patient outcomes, lower rates of complications and restenosis, and increased adoption of these devices.

3. Rising Surgical Interventions: The increasing number of surgical interventions for the treatment of cerebrovascular diseases, including intracranial stenosis, is driving the demand for stents. With the growing awareness about the benefits of stenting procedures, both patients and healthcare professionals are opting for these minimally invasive treatments to improve patient outcomes.

 

Industry Restraints & Challenges:

Report Scope

Report Coverage	Details
Segments Covered	Product, End-Use, Region
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	phenox GmbH, Medtronic, Acandis GmbH, MicroPort Scientific, MicroVention, CERENOVUS (Johnson & Johnson), Sino Medical Sciences Technology, Stryker, Balt

1. High Cost of Intracranial Stenosis Stenting: The high costs associated with intracranial stenosis stenting procedures, including the cost of stents, deployment devices, and post-operative care, pose a challenge for market growth. The affordability and reimbursement policies in different regions also impact the adoption of these stents.

2. Lack of Skilled Professionals: Performing intracranial stenting procedures requires a high level of expertise and skill. However, there is a shortage of skilled healthcare professionals proficient in these techniques, limiting the availability and accessibility of these treatments.

3. Potential Risks and Complications: Although intracranial stenosis stents have proven to be effective, they still carry the risk of complications such as restenosis, stent thrombosis, and stent migration. These complications, in addition to the potential risks associated with any surgical procedure, can hinder the market growth.

In conclusion, the global intracranial stenosis stents market is poised for significant growth in the coming years. The growing prevalence of intracranial stenosis, advancements in stent technology, increased surgical interventions, and the aging population are the primary drivers for this market. However, the high costs of stenting procedures, shortage of skilled professionals, and potential risks and complications may pose challenges to market growth.

Regional Forecast:

The intracranial stenosis stents market is expected to witness substantial growth in the forecast period in North America, Asia Pacific, and Europe.

North America

In North America, the increasing prevalence of cardiovascular diseases, rising geriatric population, and the presence of a well-established healthcare infrastructure are driving the market growth. Additionally, the swift adoption of advanced technologies and the high demand for minimally invasive procedures contribute to the growth of the intracranial stenosis stents market in North America.

Asia Pacific

In Asia Pacific, the market is expanding at a significant rate due to the growing patient population, increasing awareness about minimally invasive procedures, and the improving healthcare infrastructure in countries like China and India. Furthermore, the rise in healthcare expenditure, the presence of untapped opportunities, and rising disposable income in these regions are expected to fuel market growth.

Europe

In Europe, the market is driven by factors such as the rising prevalence of neurological disorders, advancements in stent technology, and the growing geriatric population. Moreover, the supportive reimbursement policies and increasing research and development activities in the region also contribute to the growth of the intracranial stenosis stents market.

Segmentation Analysis:

Angioplasty Balloon Catheters

Angioplasty balloon catheters are a sub-segment of the intracranial stenosis stents market. These catheters are used to dilate and open narrowed or blocked blood vessels in the brain. They are inserted into the stenotic artery and inflated to restore blood flow. The increasing prevalence of intracranial stenosis and the rising demand for minimally invasive procedures are driving the adoption of angioplasty balloon catheters. Additionally, the advancements in catheter technology, such as the development of drug-eluting balloon catheters, further contribute to their market growth.

Competitive Landscape:

 Abbott Laboratories, Medtronic, Inc., Boston Scientific Corporation, and Stryker Corporation

Abbott Laboratories, Medtronic, Inc., Boston Scientific Corporation, and Stryker Corporation are some of the key players in the intracranial stenosis stents market. These companies focus on strategic partnerships, collaborations, and acquisitions to strengthen their market position. They also invest heavily in research and development activities to develop innovative and technologically advanced stents for the treatment of intracranial stenosis. The market players adopt various growth strategies to gain a competitive edge in the market and expand their product portfolio.